March 24/25, 2011 – Caen/France – University of Caen, Human Sciences (MRSH), Esplanade de la Paix
Co-organisers:
University of Caen MRSH-CNRS; Risk Pole; CRIIGEN; ENSSER; Foundation for Citizen Sciences; GenØk; Society of Environmental Health in Western France
Programme public event: English French
Poster Session
Program & Lectures
Mar 24 (08:30) – Opening Session
Josette Travert, President, University of Caen
Jean-Karl Deschamps, Vice-President, Regional Council of Basse-Normandie
Pascal Buléon, Director, Maison de la Recherche en Sciences Humaines (MRSH), University of Caen
Corinne Lepage, Member of the European Parliament, Alliance of Liberals and Democrats for Europe (ALDE)
Angelika Hilbeck, Chairperson of ENSSER & Member of the Scientific Council of the Comité de Recherche et d’Information Indépendantes sur le génie Génétique (CRIIGEN)
Program & Lectures
lectures are currently uploaded
Mar 24 (08:30) – Opening Session
Josette Travert, President, University of Caen
Jean-Karl Deschamps, Vice-President, Regional Council of Basse-Normandie
Pascal Buléon, Director, Maison de la Recherche en Sciences Humaines (MRSH), University of Caen
Corinne Lepage, Member of the European Parliament, Alliance of Liberals and Democrats for Europe (ALDE)
Angelika Hilbeck, Chairperson of ENSSER & Member of the Scientific Council of the Comité de Recherche et d’Information Indépendantes sur le génie Génétique (CRIIGEN)
Mar 24 (09:00) – European Situation and Trends
State of the art in European assessment of technologies and biotechnologies, in European laws and legal contexts
Corinne Lepage (MEP-ALDE), France
Environmental and health risk assessment in the EU – possible improvements
David Gee, Coordinator for Emerging Issues, European Environmental Agency (EEA), Denmark
Mar 24 (10:20) – American Situation and Trends
State of the art and future possible directions in American environmental and health assessments of technologies and biotechnologies
Prof Louise Vandelac, Centre de recherche interdisciplinaire sur la biologie, la santé et l’environnement (CINBOISE), University of Quebec in Montreal, Canada
Mar 24 (10:40) – Health Issues
What is really environmental health? The case of rivers polluted by medicinal drugs, chemicals and pesticides or GMO residues
Dr Joël Spiroux de Vendômois, Society for Environmental Health – Normandie, France
Environmental health risk assessment in the EU: state of the art and future directions
Dr Andreas Gies, Federal Environment Agency (Umweltbundesamt, UBA), Germany
The nutritional assessment of GMOs before commercialization, how to approach a comprehensive assessment
Prof Federico Infascelli & Dr Raffaella Tudisco, University of Napoli, Italy
The genetic engineering assessment itself is not holistic – implications on public transparency, regional agriculture in Italy, and on labeling as well as future possibilities
Prof Marcello Buiatti, University of Firenze & Italian Commission on Genetic Engineering, Italy
What possible health and environmental assessment for nanotechnologies?
Prof Julian Filser & Dr Jan Köser, University of Bremen, Germany
How the neglected effects of chemicals, pesticides, drugs, biotechnologies and nanotechnologies can be taken into account in the future
Prof Gilles-Eric Séralini, University of Caen & CRIIGEN, France
Mar 24 (14:00) – Environmental and Geographical Issues
The lack of assessment of the impact new technologies on the microbial world and the soil – possible improvements
Dr Christian Vélot, University Paris-South (Orsay), France
Bringing the geographical approach to assessment and management of technological risks: application to Normandy
Prof Olivier Maquaire, University of Caen, France
Environmental assessment of biotechnologies in the future
Dr. Angelika Hilbeck, Swiss Federal Institute of Technology Zurich (ETH Zürich), Switzerland
Mar 24 (15:30) – Economical, Legal and Ethical Issues
Pesticide and agricultural GMO registration in the EU: internal controversies
Dr. András Székács, Department of Ecotoxicology and Environmental Chemistry, Plant Protection Institute, Hungarian Academy of Sciences, Hungary
Economical assessment of technologies and biotechnologies : past, present and future: how to encompass it in biological assessment?
Dr. Iulie Aslaksen, Statistics Norway & GenØk, Norway
Lacks and possible improvements in European Union law concerning GMOs
Prof Jean-Michel Panoff & Dr Marie-Pierre Maurin, University of Caen & CRIIGEN, France
Patents and sustainable development in the Southern and Northern hemispheres
Dr. Hartmut Meyer, Scientific Coordinator, ENSSER
Science policy and anomie – Risk appraisal interface
Dr. David Quist, GenØk, Norway
Mar 25 (08:30) – Social Issues
How to better involve the society in technological and biotechnological assessments?
Claudia Neubauer, Fondation Citoyennes Science (FSC), France
Public participation in EU assessment of biotechnologies and future directions – a European study
Dr Frédérick Lemarchand, Risk Cluster Sociology, University of Caen, France
Nanotechnologies risk assessment
Prof Christian Papilloud, Sociology, University of Caen, France
Social acceptability of new technologies. What about the future?
Dr Michelle Dobré, Centre National de la Recherche Scientifique (CNRS), Centre d’Etude et de Recherche sur les Risques et les Vulnérabilités (C.E.R.R.e.V.), University of Caen, France
Public information and participation in technology and biotechnology assessment
Prof Mercy W. Kamara, University of Roskilde, Denmar
